IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | 0.0% | 100 | +177.8% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 36 | -29.4% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 51 | -63.0% | 0.00% | – |
Q3 2021 | $3,000 | +50.0% | 138 | +46.8% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 94 | +70.9% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 55 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | +200.0% | 55 | +22.2% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 45 | +66.7% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 27 | -22.9% | 0.00% | – |
Q4 2019 | $1,000 | – | 35 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |